Author: BusinessWire

Exciting New Features to its Pharmacometric Communication and Collaboration Platform BUFFALO, N.Y.–(BUSINESS WIRE)–Cognigen Corporation, a Simulations Plus company (Nasdaq: SLP)…

Experienced biopharma leader brings business development, strategy and company-building expertise to accelerate Celsius’ growth CAMBRIDGE, Mass.–(BUSINESS WIRE)–Celsius Therapeutics, a company…

DUBLIN–(BUSINESS WIRE)–The “The Market for Bioelectronic Medicine: 2020-2025” report has been added to ResearchAndMarkets.com’s offering. The Market for Bioelectronic Medicine:…

Boehringer Ingelheim and University of Dundee achieve milestone in collaboration aimed at developing novel protein degradation medicines Results published in…

SAN DIEGO–(BUSINESS WIRE)–Progenity, Inc., a privately held biotechnology company developing precision medicine solutions across genomic/epigenomic, proteomic, and microbiomic diagnostic and…

MARTINSRIED, Germany–(BUSINESS WIRE)–#SCID—SIRION Biotech GmbH (“SIRION”) today announced the entry into a license agreement with the National Institute of Allergy…

Proven leader with extensive corporate strategy experience in the biotechnology sector Dr. Eddy Littler to remain as Chief Operating Officer…

Company to Share Updated Clinical Data on AR101 and Provide Perspective on Its Value to Society BRISBANE, Calif.–(BUSINESS WIRE)–Aimmune Therapeutics,…

PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify HNSCC patients for treatment with KEYTRUDA® (pembrolizumab)…

DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies…